What is obstructive sleep apnea?
Obstructive sleep apnea (OSA) is a common sleep disorder in infants, especially those with Down syndrome. It is characterized by pauses in breathing during sleep, which can affect development.
The results of the Respire-21 study
The Respire-21 study followed infants with Down syndrome for 36 months after early diagnosis and treatment of OSA. The results show that these children performed better on certain neurocognitive and behavioral assessments compared to those who did not receive early screening.
At 60 months, children who received early treatment continued to show advantages, particularly in the areas of learning and social skills.
What this means for families
For families of children with Down syndrome, these results highlight the importance of early screening and treatment of obstructive sleep apnea. While significant benefits have been observed for certain skills, it is worth noting that no advantages were found for language and communication outcomes.
This may encourage parents to discuss with their doctors the screening and treatment options to enhance their child's development.
This article is provided for information only and does not replace medical advice. For any question about your own situation, talk to your doctor.
